Literature DB >> 1394441

Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein.

S F Purvis1, D L Georges, T M Williams, M M Lederman.   

Abstract

The Jurkat T cell line was stably transfected with an Epstein-Barr virus-based episomal replicon designed to express high levels of the HIV-1 Tat protein. After selection in hygromycin B, high-level Tat activity was detected in 3 of 18 transfected cell lines. After stimulation with phytohemagglutinin (PHA) and phorbol myristate acetate (PMA), Tat transfectants with high Tat expression showed diminished expression of interleukin-2 (IL-2) and the interleukin-2 receptor alpha chain (IL-2R) when compared to untransfected Jurkat cells or Jurkat cell lines transfected with the parent control plasmid. Sublines derived from the high-level Tat transfectants with reduced Tat activity showed normalization of PHA/PMA-induced IL-2 expression. Northern analysis showed diminished expression of IL-2 and IL-2R mRNA in the stimulated Tat transfectants. Inhibition of IL-2 and IL-2R expression by the HIV-1 Tat protein may contribute to the immune suppression that characterizes HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394441     DOI: 10.1016/0008-8749(92)90223-c

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  12 in total

1.  Mechanism of action of interleukin-2 (IL-2)-Bax, an apoptosis-inducing chimaeric protein targeted against cells expressing the IL-2 receptor.

Authors:  Rami Aqeilan; Rotem Kedar; Ahmi Ben-Yehudah; Haya Lorberboum-Galski
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

2.  Human immunodeficiency virus type 1 Nef does not alter T-cell sensitivity to antigen-specific stimulation.

Authors:  K A Page; W C van Schooten; M B Feinberg
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

3.  Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule.

Authors:  F Cottrez; F Manca; A G Dalgleish; F Arenzana-Seisdedos; A Capron; H Groux
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

4.  Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells.

Authors:  M O Westendorp; M Li-Weber; R W Frank; P H Krammer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

5.  Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells.

Authors:  S C Flores; J C Marecki; K P Harper; S K Bose; S K Nelson; J M McCord
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

6.  Human immunodeficiency virus Tat induces functional unresponsiveness in T cells.

Authors:  N Chirmule; S Than; S A Khan; S Pahwa
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

7.  HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes.

Authors:  J D Weissman; J A Brown; T K Howcroft; J Hwang; A Chawla; P A Roche; L Schiltz; Y Nakatani; D S Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

Review 8.  Insights into the role of progranulin in immunity, infection, and inflammation.

Authors:  Jinlong Jian; Jessica Konopka; Chuanju Liu
Journal:  J Leukoc Biol       Date:  2012-10-22       Impact factor: 4.962

9.  Interactions between human immunodeficiency virus type 1 and human cytomegalovirus in human term syncytiotrophoblast cells coinfected with both viruses.

Authors:  F D Tóth; P Mosborg-Petersen; J Kiss; G Aboagye-Mathiesen; H Hager; C B Juhl; L Gergely; M Zdravkovic; J Aranyosi; L Lampé
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  Displacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells.

Authors:  P Pavan Kumar; Prabhat Kumar Purbey; Dyavar S Ravi; Debashis Mitra; Sanjeev Galande
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.